Nickolas Boutris, MD
Sports Medicine · Houston, TXNPI 1952745804
Payments from drug & device makers
Across 77 payments — averaging $180.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Medinc Of Texas$4K
- Stryker$2K
- Arthrex$1K
- Pacira Therapeutics, Inc.$189
- Surgalign Spine Technologies, Inc.$166
- plus $438 from 6 others
What the payments were for
- Travel & lodging$5,92443%
- Food & beverage$4,30231%
- Education$3,67026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 35 | $6,423 |
| Medinc Of Texas | 4 | $3,551 |
| Stryker | 10 | $2,121 |
| Arthrex | 13 | $1,009 |
| Pacira Therapeutics, Inc. | 5 | $189 |
| Surgalign Spine Technologies, Inc. | 2 | $166 |
| FX Shoulder Solutions, Inc | 1 | $162 |
| Bone Support Inc. | 1 | $150 |
| Vericel Corporation | 2 | $42 |
| Pacira Pharmaceuticals Incorporated | 1 | $40 |
| Abbott | 2 | $29 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Q-FIX$3,066
- Healicoil$2,361
- ACUFEX Meniscal Root Repair$2,150
- CAP-FIX$1,898
- NOVOSTITCH$1,898
- HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET$1,558
- Q-FIX Hip$1,515
- Hipstruments$1,515
- Bioinductive Implant with Arthroscopic Delivery System - Medium$1,322
- Mini-Open Latarjet$1,168
- MICRORAPTOR$1,168
- AETOS Shoulder System$1,168
- CERAMENTBONE VOID FILLER$150
- CERAMENT G$150
- CINCHLOCK SS$146
- Bone Anchors with Arthroscopic Delivery System$141
- REUNION$140
- Zilretta$122
- Acufex Director$116
- REGENESORB$116
How this compares
$13,896 in reported general payments places this provider in the 75th percentile of 437 sports medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 18 | $262 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $155 |
| Meloxicam | 21 | $65 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Houston
- Walter LoweHouston$1.4M
- David BrownHouston$920K
- James GregoryHouston$848K
- Matthew HiggsHouston$634K
- Robert FullickHouston$141K
- Patrick McCullochHouston$136K
- Joshua HarrisHouston$109K
- David LintnerHouston$45K
- Mark AdickesHouston$35K
- Mufaddal GomberaHouston$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.